Rotenone induces K ATP channel opening in PC12 cells in association with the expression of tyrosine hydroxylase

Oncology Reports

Volumn 28, Issue 4, 2012, Pages 1376-1384

  Bai, Qunhua ^a   He, Junlin ^a   Qiu, Jingfu ^a   Wang, Yang ^a   Wang, Shibo ^a   Xiu, Yun ^a   Yu, Chao ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

ATP sensitive potassium channel; Patch clamp; Pheochromocytoma cell line; Rotenone; Tyrosine hydroxylase

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; ROTENONE; TYROSINE 3 MONOOXYGENASE; DOPAMINE; GLIBENCLAMIDE; PINACIDIL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DEGENERATION; CELL ENERGY; CELL STRAIN; CELL STRESS; CELL VIABILITY; CHANNEL GATING; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; ENERGY STRESS; ENZYME ACTIVATION; GENE EXPRESSION; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PATCH CLAMP; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENERGY METABOLISM; METABOLISM; PC12 CELL;

ANIMALS; DOPAMINE; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; GLYBURIDE; KATP CHANNELS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PATCH-CLAMP TECHNIQUES; PC12 CELLS; PINACIDIL; RATS; REACTIVE OXYGEN SPECIES; ROTENONE; TYROSINE 3-MONOOXYGENASE;

EID: 84866467248     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1959     Document Type: Article

References (27)

1. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV and Greenamyre JT: Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306, 2000.
2. Dawson TM and Dawson VL: Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822, 2003.
3. Di Monte DA: The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol 2: 531-538, 2003.
4. Hartley A, Stone JM, Heron C, Cooper JM and Schapira AH: Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 63: 1987-1990, 1994.
5. Pitkanen S and Robinson BH: Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 98: 345-351, 1996.
6. Votyakova TV and Reynolds IJ: ΔΨm-dependent and -independent production of reactive oxygen species by rat brain mitochondria. J Neurochem 79: 266-277, 2001.
7. Liss B, Haeckel O, Wildmann J, Miki T, Seino S and Roeper J: K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons. Nat Neurosci 8: 1742-1751, 2005.
8. Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J and Agid Y: Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in parkinson's disease: an in situ hybridization study. Neuroscience 38: 245-253, 1990.
9. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
10. Wu C, Yang K, Liu Q, Wakui M, Jin GZ, Zhen XC and Wu J: Tetrahydroberberine blocks ATP-sensitive potassium channels in dopamine neurons acutely-dissociated from rat substantia nigra pars compacta. Neuropharmacology 59: 567-572, 2010.
11. Koshimura K, Tanaka J, Murakami Y and Kato Y: Effect of high concentration of glucose on dopamine release from pheochromocytoma-12 cells. Metabolism 52: 922-926, 2003.
12. Tai KK, McCrossan ZA and Abbott GW: Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. J Neurochem 84: 1193-1200, 2003.
13. Lamensdorf I, He LP, Nechushtan A, Harvey-White J, Eisenhofer G, Milan R, Rojas E and Kopin IJ: Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells. Eur J Pharmacol 388: 147-154, 2000.
14. Liss B and Roeper J: ATP-sensitive potassium channels in dopaminergic neurons: transducers of mitochondrial dysfunction. News Physiol Sci 16: 214-217, 2001.
15. Zingman LV, Hodgson DM, Bast PH, Kane GC, Perez-Terzic C, Gumina RJ, Pucar D, Bienengraeber M, Dzeja PP, Miki T, et al: Kir6.2 is required for adaptation to stress. Proc Natl Acad Sci USA 99: 13278-13283, 2002.
16. ATP channelopathies: diseases of metabolic homeostasis. Pflugers Arch 460: 295-306, 2010.
17. + conductances in CART and NPY/AgRP expressing neurons of the hypothalamic arcuate nucleus. Neuroscience 144: 815-824, 2007.
18. Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A and Greenamyre JT: Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23: 10756-10764, 2003.
19. Tai KK and Truong DD: Activation of ATP-sensitive potassium channel confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease. J Neurosci Res 69: 559-566, 2002.
20. Saravanan KS, Sindhu KM and Mohanakumar KP: Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease. Brain Res 1049: 147-155, 2005.
21. Liu YM, Jiang B, Bao YM and An LJ: Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells. Toxicol In Vitro 22: 430-437, 2008.
22. + channel in the pancreatic β-cell. FEBS Lett 319: 128-132, 1993.
23. + channel channel/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol 38: 895-905, 2005.
24. Kastner A, Hirsch E, Agid Y and Javoy-Agid F: Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res 606: 341-345, 1993.
25. Lee TM, Lin MS and Chang NC: Effect of pravastatin on sympathetic reinnervation in postinfarcted rats. Am J Physiol Heart Circ Physiol 293: H3617-H3626, 2007.
26. He XB, Yi SH, Rhee YH, Kim H, Han YM, Lee SH, Lee H, Park CH, Lee YS, Richardson E, et al: Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications. Stem Cells 29: 1861-1873, 2011.
27. Kilbourne EJ, McMahon A and Sabban EL: Membrane depolarization by isotonic or hypertonic KCl: differential effects on mRNA levels of tyrosine hydroxylase and dopamine β-hydroxylase mRNA in PC12 cells. J Neurosci Methods 40: 193-202, 1991.